Gartner Research

Hype Cycle for Telemedicine, 2014

Published: 14 July 2014

ID: G00263104

Analyst(s): Zafar Chaudry, M.D.

Summary

Gartner's 2014 Hype Cycle for Telemedicine highlights the maturity and adoption of telemedicine technologies so that healthcare delivery organizations, government healthcare agencies, and healthcare payers can define business strategies and prioritize their investments in telemedicine projects.

Table Of Contents

Analysis

  • What You Need to Know
  • The Hype Cycle
  • The Priority Matrix
  • Off the Hype Cycle
  • On the Rise
    • Patient Decision Aids (Healthcare Provider)
    • Telepsychiatry
    • Telesurgery
    • Teleaudiology
    • Digital Telepathology
  • At the Peak
    • Healthcare-Assistive Robots
    • Medication Compliance Management
    • Real-Time Virtual Visits
    • Teletrauma
    • Personal Health Management Tools — Healthcare Providers
  • Sliding Into the Trough
    • Continua 2014
    • Telepharmacy
    • Mobile Health Monitoring
    • Video Visits
    • Teleretinal Imaging
    • Home Health Monitoring
  • Climbing the Slope
    • Telestroke
    • Teledermatology
    • Remote Electrocardiogram Monitoring
    • Patient Portals
    • Healthcare Provider E-Visits
  • Entering the Plateau
    • Remote ICU
  • Appendixes
    • Hype Cycle Phases, Benefit Ratings and Maturity Levels

Gartner Recommended Reading

©2021 Gartner, Inc. and/or its affiliates. All rights reserved. Gartner is a registered trademark of Gartner, Inc. and its affiliates. This publication may not be reproduced or distributed in any form without Gartner’s prior written permission. It consists of the opinions of Gartner’s research organization, which should not be construed as statements of fact. While the information contained in this publication has been obtained from sources believed to be reliable, Gartner disclaims all warranties as to the accuracy, completeness or adequacy of such information. Although Gartner research may address legal and financial issues, Gartner does not provide legal or investment advice and its research should not be construed or used as such. Your access and use of this publication are governed by Gartner’s Usage Policy. Gartner prides itself on its reputation for independence and objectivity. Its research is produced independently by its research organization without input or influence from any third party. For further information, see Guiding Principles on Independence and Objectivity.

Already have a Gartner Account?

Become a client

Learn how to access this content as a Gartner client.